Snowden Capital Advisors LLC Biogen Inc. Transaction History

Snowden Capital Advisors LLC

  • $3.31 Billion
  • Q2 2024

A detailed history of Snowden Capital Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 1,307 shares of BIIB stock, worth $227,143. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,307
Previous 1,201 8.83%
Holding current value
$227,143
Previous $258,000 17.05%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$190.52 - $236.72 $20,195 - $25,092
106 Added 8.83%
1,307 $302,000
Q1 2024

May 15, 2024
BUY
$212.02 - $267.71 $12,933 - $16,330
61 Added 5.35%
1,201 $258,000
Q4 2023

Feb 14, 2024
SELL
$222.59 - $267.94 $6,009 - $7,234
-27 Reduced 2.31%
1,140 $294,000
Q3 2023

Nov 14, 2023
SELL
$253.3 - $285.89 $107,399 - $121,217
-424 Reduced 26.65%
1,167 $299,000
Q2 2023

Aug 14, 2023
BUY
$275.25 - $318.06 $10,734 - $12,404
39 Added 2.51%
1,591 $453,000
Q1 2023

May 15, 2023
BUY
$256.56 - $292.34 $18,215 - $20,756
71 Added 4.79%
1,552 $431,000
Q4 2022

Feb 13, 2023
BUY
$252.44 - $306.72 $110,316 - $134,036
437 Added 41.86%
1,481 $410,000
Q3 2022

Nov 09, 2022
SELL
$194.69 - $268.46 $12,265 - $16,912
-63 Reduced 5.69%
1,044 $278,000
Q2 2022

Aug 12, 2022
BUY
$187.54 - $223.02 $207,606 - $246,883
1,107 New
1,107 $225,000
Q1 2022

May 16, 2022
SELL
$193.77 - $244.14 $75,570 - $95,214
-390 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$223.92 - $287.77 $87,328 - $112,230
390 New
390 $93,000
Q2 2021

Jan 08, 2024
SELL
$259.0 - $414.71 $31,598 - $50,594
-122 Reduced 16.38%
623 $216 Million
Q1 2021

Jan 08, 2024
SELL
$242.95 - $284.63 $439,739 - $515,180
-1,810 Reduced 70.84%
745 $208 Million
Q4 2020

Jan 08, 2024
BUY
$236.26 - $355.63 $603,644 - $908,634
2,555 New
2,555 $626 Million
Q4 2019

Jan 08, 2024
SELL
$220.06 - $304.07 $12.5 Million - $17.2 Million
-56,600 Closed
0 $0
Q3 2019

Jan 08, 2024
SELL
$217.44 - $243.88 $14.9 Million - $16.7 Million
-68,400 Reduced 54.72%
56,600 $132 Million
Q2 2019

Jan 08, 2024
BUY
$219.29 - $241.72 $27.4 Million - $30.2 Million
125,000 New
125,000 $141 Million
Q1 2019

Jan 08, 2024
SELL
$216.71 - $338.96 $258,751 - $404,718
-1,194 Closed
0 $0
Q4 2018

Jan 08, 2024
SELL
$278.5 - $352.75 $6,127 - $7,760
-22 Reduced 1.81%
1,194 $359 Million
Q3 2018

Jan 08, 2024
BUY
$293.51 - $383.83 $14,381 - $18,807
49 Added 4.2%
1,216 $430 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email